- Home
- NBXG vs INMD Comparison
NBXG vs INMD Comparison
Compare NBXG & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBXG
- INMD
- Stock Information
- Founded
- NBXG 2021
- INMD 2008
- Country
- NBXG United States
- INMD Israel
- Employees
- NBXG N/A
- INMD N/A
- Industry
- NBXG Trusts Except Educational Religious and Charitable
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NBXG Finance
- INMD Health Care
- Exchange
- NBXG Nasdaq
- INMD Nasdaq
- Market Cap
- NBXG 1.1B
- INMD 957.6M
- IPO Year
- NBXG N/A
- INMD 2019
- Fundamental
- Price
- NBXG $15.46
- INMD $16.38
- Analyst Decision
- NBXG
- INMD Hold
- Analyst Count
- NBXG 0
- INMD 6
- Target Price
- NBXG N/A
- INMD $16.81
- AVG Volume (30 Days)
- NBXG 243.7K
- INMD 691.7K
- Earning Date
- NBXG 01-01-0001
- INMD 10-29-2025
- Dividend Yield
- NBXG 10.25%
- INMD N/A
- EPS Growth
- NBXG N/A
- INMD 46.63
- EPS
- NBXG N/A
- INMD 2.54
- Revenue
- NBXG N/A
- INMD $401,561,000.00
- Revenue This Year
- NBXG N/A
- INMD N/A
- Revenue Next Year
- NBXG N/A
- INMD $5.30
- P/E Ratio
- NBXG N/A
- INMD $5.90
- Revenue Growth
- NBXG N/A
- INMD N/A
- 52 Week Low
- NBXG $9.31
- INMD $13.14
- 52 Week High
- NBXG $12.23
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- NBXG 62.73
- INMD 70.69
- Support Level
- NBXG $15.37
- INMD $14.90
- Resistance Level
- NBXG $15.61
- INMD $15.47
- Average True Range (ATR)
- NBXG 0.16
- INMD 0.41
- MACD
- NBXG -0.01
- INMD 0.09
- Stochastic Oscillator
- NBXG 64.07
- INMD 98.79
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.